Quell launches chill phase 1/2 trial for novel cartreg therapy

3rd March 2026 Uncategorised 0

Company targets new approach to treating rheumatoid arthritis and systemic sclerosis

More: Quell launches chill phase 1/2 trial for novel cartreg therapy
Source: News